Cargando…

Assessing cardiac safety in oncology drug development

Detalles Bibliográficos
Autores principales:	Seltzer, Jonathan H, Gintant, Gary, Amiri-Kordestani, Laleh, Singer, Jack, Koplowitz, Luana Pesco, Moslehi, Javid J, Barac, Ana, Yu, Anthony F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7316329/ https://www.ncbi.nlm.nih.gov/pubmed/31202099 http://dx.doi.org/10.1016/j.ahj.2019.04.010

Ejemplares similares

21st Century Cardio-Oncology: Identifying Cardiac Safety Signals in the Era of Personalized Medicine
por: Sheng, Calvin Chen, et al.
Publicado: (2016)

Oncology approvals in 2020: a year of firsts in the midst of a pandemic
por: Amiri-Kordestani, Laleh, et al.
Publicado: (2021)

Evaluation of Pharmacokinetics and Dose Proportionality of Diazepam After Intranasal Administration of NRL‐1 to Healthy Volunteers
por: Tanimoto, Sarina, et al.
Publicado: (2020)

Biorelevant In Vitro Skin Permeation Testing and In Vivo Pharmacokinetic Characterization of Lidocaine from a Nonaqueous Drug-in-Matrix Topical System
por: Greuber, Emileigh, et al.
Publicado: (2021)

Pharmacokinetics of the Melanocortin Type 1 Receptor Agonist PL8177 After Subcutaneous Administration
por: Dodd, John, et al.
Publicado: (2021)

Cardio-Oncology: Time to Get More Mechanistic
por: Moslehi, Javid, et al.
Publicado: (2017)

Bioavailability and safety of diazepam intranasal solution compared to oral and rectal diazepam in healthy volunteers
por: Hogan, R. Edward, et al.
Publicado: (2020)

US Food and Drug Administration regulatory updates in neuro-oncology
por: Mehta, Gautam U., et al.
Publicado: (2021)

Myocarditis Associated with Immune Checkpoint Inhibitors: An Expert Consensus on Data Gaps and a Call to Action
por: Neilan, Tomas G., et al.
Publicado: (2018)

Vascular medicine and cardio-oncology – A new, evolving clinical frontier
por: Versmissen, Jorie, et al.
Publicado: (2020)

To Adjudicate or Not Adjudicate: That Is the Question
por: Hicks, Karen A., et al.
Publicado: (2022)

Reverse Cardio‐Oncology: Cancer Development in Patients With Cardiovascular Disease
por: Aboumsallem, Joseph Pierre, et al.
Publicado: (2020)

T vector velocity: A new ECG biomarker for identifying drug effects on cardiac ventricular repolarization
por: Bystricky, Werner, et al.
Publicado: (2019)

Patient‐Friendly Language to Facilitate Treatment Choice for Patients with Cancer
por: Kim, Janice, et al.
Publicado: (2019)

Antenatal and perinatal factors influencing neonatal blood pressure: a systematic review
por: Rabe, Heike, et al.
Publicado: (2021)

Tales of the Unexpected: The Value of Case Reports in CardioOncology
por: Manisty, Charlotte, et al.
Publicado: (2019)

Novel SIL1 mutations in consanguineous Pakistani families mapping to chromosomes 5q31
por: Riazuddin, S. Amer, et al.
Publicado: (2009)

Strain Imaging in Cardio-Oncology
por: Liu, Jennifer E., et al.
Publicado: (2020)

Identification of Drug-Induced Multichannel Block and Proarrhythmic Risk in Humans Using Continuous T Vector Velocity Effect Profiles Derived From Surface Electrocardiograms
por: Bystricky, Werner, et al.
Publicado: (2020)

Recent developments in using mechanistic cardiac modelling for drug safety evaluation
por: Davies, Mark R., et al.
Publicado: (2016)

Cardiac Magnetic Resonance in Cardio-Oncology: Advantages, Importance of Expediency, and Considerations to Navigate Pre-Authorization
por: O’Quinn, Rupal, et al.
Publicado: (2021)

Implementation of Cardio-Oncology Training for Cardiology Fellows
por: Tuzovic, Mirela, et al.
Publicado: (2020)

Systematic Review of PD‐1/PD‐L1 Inhibitors in Oncology: From Personalized Medicine to Public Health
por: Chang, Elaine, et al.
Publicado: (2021)

Editorial: Recent Advances in Cardiotoxicity Testing
por: Mohamed, Tamer M. A., et al.
Publicado: (2021)

Immune Checkpoint Inhibitor Myocarditis Treatment Strategies and Future Directions
por: Moslehi, Javid, et al.
Publicado: (2022)

Cardio-Oncology and the Intersection of Cancer and Cardiotoxicity: The Role of Palliative Care
por: Cheng, Richard K., et al.
Publicado: (2019)

The COVID-19 pandemic and cardiovascular issues in clinical trials: Practical and regulatory issues in remote monitoring of cardiac safety
por: Seltzer, Jonathan, et al.
Publicado: (2022)

The economic underpinnings of the drug epidemic
por: Seltzer, Nathan
Publicado: (2020)

Longitudinal correlation of biomarkers of cardiac injury, inflammation, and coagulation to outcome in hospitalized COVID-19 patients
por: Li, Chenze, et al.
Publicado: (2020)

Left ventricular mass by cardiac magnetic resonance imaging and adverse cardiovascular outcomes in patients treated with anthracycline-based chemotherapy
por: Neilan, Tomas G, et al.
Publicado: (2012)

Bringing a genomic perspective to the safety of drug treatment in oncology
por: Innocenti, Federico
Publicado: (2017)

Incorporating Exercise Training into Cardio-Oncology Care: Current Evidence and Opportunities: JACC: CardioOncology State-of-the-Art Review
por: Wilson, Rebekah L., et al.
Publicado: (2023)

Safety of MRI in patients with retained cardiac leads
por: Nguyen, Bach T., et al.
Publicado: (2021)

How to Follow, Manage and Treat Cardiac Dysfunction in Patients With Her2+ Breast Cancer
por: Blaes, Anne, et al.
Publicado: (2020)

Considerations for an In Vitro, Cell-Based Testing Platform for Detection of Drug-Induced Inotropic Effects in Early Drug Development. Part 2: Designing and Fabricating Microsystems for Assaying Cardiac Contractility With Physiological Relevance Using Human iPSC-Cardiomyocytes
por: Ribeiro, Alexandre J. S., et al.
Publicado: (2019)

Inflammatory Biomarkers to Detect Immune Checkpoint Inhibitor-Associated Cardiotoxicity in Lung Cancer Patients: Ready for Prime Time?
por: Aras, Mandar A., et al.
Publicado: (2020)

Concepts in cardiac oncology
por: Bisceglia, Irma, et al.
Publicado: (2020)

Assessing pragmatics in early childhood with the Language Use Inventory across seven languages
por: Pesco, Diane, et al.
Publicado: (2023)

Sponsors’ and investigative staffs' perceptions of the current investigational new drug safety reporting process in oncology trials
por: Perez, Raymond, et al.
Publicado: (2017)

Heart Failure and Breast Cancer Therapies: Moving Towards Personalized Risk Assessment
por: Francis, Sanjeev A., et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_ae2hvkcnt22ipv7fc3d7mc69dq